235 related articles for article (PubMed ID: 7569954)
21. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H.
Higashi H; Suzuki-Takahashi I; Saitoh S; Segawa K; Taya Y; Okuyama A; Nishimura S; Kitagawa M
Eur J Biochem; 1996 Apr; 237(2):460-7. PubMed ID: 8647086
[TBL] [Abstract][Full Text] [Related]
22. Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.
Yeh CT; Lu SC; Chen TC; Peng CY; Liaw YF
Cancer Res; 2000 Sep; 60(17):4697-700. PubMed ID: 10987270
[TBL] [Abstract][Full Text] [Related]
23. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
24. Purification and crystallization of the CDK-associated protein phosphatase KAP expressed in Escherichia coli.
Hanlon N; Barford D
Protein Sci; 1998 Feb; 7(2):508-11. PubMed ID: 9521129
[TBL] [Abstract][Full Text] [Related]
25. The N-terminal domains of cyclin-dependent kinase inhibitory proteins block the phosphorylation of cdk2/Cyclin E by the CDK-activating kinase.
Rank KB; Evans DB; Sharma SK
Biochem Biophys Res Commun; 2000 May; 271(2):469-73. PubMed ID: 10799321
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.
Connell-Crowley L; Solomon MJ; Wei N; Harper JW
Mol Biol Cell; 1993 Jan; 4(1):79-92. PubMed ID: 8443411
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation and activation of the Xenopus Cdc25 phosphatase in the absence of Cdc2 and Cdk2 kinase activity.
Izumi T; Maller JL
Mol Biol Cell; 1995 Feb; 6(2):215-26. PubMed ID: 7787247
[TBL] [Abstract][Full Text] [Related]
28. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15.
Sebastian B; Kakizuka A; Hunter T
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3521-4. PubMed ID: 8475101
[TBL] [Abstract][Full Text] [Related]
29. Regulation of CAK kinase activity by p53.
Schneider E; Montenarh M; Wagner P
Oncogene; 1998 Nov; 17(21):2733-41. PubMed ID: 9840937
[TBL] [Abstract][Full Text] [Related]
30. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.
Fisher RP; Morgan DO
Cell; 1994 Aug; 78(4):713-24. PubMed ID: 8069918
[TBL] [Abstract][Full Text] [Related]
31. [Expression of sdi1, a potent inhibitor of cdk2 kinase, cdk2 and G1 cyclins and mutation of sdi1 in human gastric carcinomas].
Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Tahara H; Noda A; Tahara E
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():180. PubMed ID: 7611786
[TBL] [Abstract][Full Text] [Related]
32. Cyclin E uses Cdc6 as a chromatin-associated receptor required for DNA replication.
Furstenthal L; Kaiser BK; Swanson C; Jackson PK
J Cell Biol; 2001 Mar; 152(6):1267-78. PubMed ID: 11257126
[TBL] [Abstract][Full Text] [Related]
33. Requirement of Cyclin/Cdk2 and protein phosphatase 1 activity for chromatin assembly factor 1-dependent chromatin assembly during DNA synthesis.
Keller C; Krude T
J Biol Chem; 2000 Nov; 275(45):35512-21. PubMed ID: 10938080
[TBL] [Abstract][Full Text] [Related]
34. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.
Hoffmann I; Draetta G; Karsenti E
EMBO J; 1994 Sep; 13(18):4302-10. PubMed ID: 7523110
[TBL] [Abstract][Full Text] [Related]
35. A cyclin associated with the CDK-activating kinase MO15.
Mäkelä TP; Tassan JP; Nigg EA; Frutiger S; Hughes GJ; Weinberg RA
Nature; 1994 Sep; 371(6494):254-7. PubMed ID: 8078587
[TBL] [Abstract][Full Text] [Related]
36. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
37. Regulation of cyclin-dependent kinase 2 activity by ceramide.
Lee JY; Bielawska AE; Obeid LM
Exp Cell Res; 2000 Dec; 261(2):303-11. PubMed ID: 11112337
[TBL] [Abstract][Full Text] [Related]
38. Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/Cdk2.
Gabrielli BG; Clark JM; McCormack AK; Ellem KA
J Biol Chem; 1997 Nov; 272(45):28607-14. PubMed ID: 9353326
[TBL] [Abstract][Full Text] [Related]
39. Fission yeast Csk1 is a CAK-activating kinase (CAKAK).
Hermand D; Pihlak A; Westerling T; Damagnez V; Vandenhaute J; Cottarel G; Mäkelä TP
EMBO J; 1998 Dec; 17(24):7230-8. PubMed ID: 9857180
[TBL] [Abstract][Full Text] [Related]
40. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
